JPT supports EURIPRED free reagents and services program

EURIPRED (European Research Infrastructures for Poverty Related Diseases) in collaboration with JPT expands and continues its offer on free reagents and services to researchers. EURIPRED’s objective is to reinforce the knowledge infrastructure across poverty related diseases (PRD). The ultimate aim is to speed up the development of new tools to combat major PRD such as Tuberculosis, HIV, Malaria, Hepatitis B and Hepatitis C. Scientists from 17 research partners in 10 countries collaborate in this program. One of the key activities is providing reference reagents, services and trainings for free such as:

Free Services
Access to vaccine formulation studies including compatibility and stability studies by Vaccine Formulation Laboratory (VFL, UNIL)
Access to biological materials and reference standards facilitated by the National Institute of Biological Standards and Control (NIBSC, UK)
Access to microarray facility for screening and evaluation facilitated by JPT Peptide Technologies (Berlin, Germany)

Free Reference Standards & Reagents
HIV, TB and HCV PepMix™ Peptide Pools
RepliTope™ Antigen Collection M.tuberculosis Peptide Microarrays
Various M.tuberculosis antigens
HIV+ clinical samples recently collected in the UK and India
Products in the CFAR Catalogue

Free On Site Lab Course
Mucosal vaccination strategies and immunomonitoring focusing on FACS analysis (multifunctional T cells and intracellular cytokines) at Helmholtz Centre for Infection Research (HZI, Braunschweig, Germany)

For further information, application and contacts please visit EURIPRED

Stay in touch and be the first to receive the latest news!